{"id":"W2971213137","doi":"10.1016/j.clml.2019.07.116","title":"Clinical Benefit of Glasdegib Plus Low-Dose Cytarabine in Patients with De Novo and Secondary Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Cytarabine; Medicine; Myeloid leukemia; Internal medicine; Oncology; Randomized controlled trial; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002621117,0.0005008211,0.003202999,0.0002948318,0.0000525614,0.00002209208,0.0004758177,0.0007662707,0.00004406423],"category_scores_gemma":[0.001155601,0.0004107179,0.001052743,0.0005969831,0.001088045,0.00002000481,0.0003970264,0.0003432873,0.000006303069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002871722,"about_ca_system_score_gemma":0.00180055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006475971,"about_ca_topic_score_gemma":0.0001191753,"domain_scores_codex":[0.9943559,0.0006543628,0.002907414,0.001114394,0.0004093435,0.0005585849],"domain_scores_gemma":[0.9960755,0.00112064,0.001158457,0.0009747748,0.0003751245,0.0002954745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5948808,0.0009528422,0.3439238,0.0001160415,0.005778582,0.00004695979,0.0001025671,0.0001496252,0.002928875,0.00001693015,0.00002611258,0.05107686],"study_design_scores_gemma":[0.4790021,0.002672361,0.5143843,0.00009507715,0.001472981,0.000003641451,0.00001312992,0.0004554875,0.00156346,0.00001285358,0.00002605859,0.0002985256],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997183,0.0004969766,0.0001666307,0.00001939836,0.0003183686,0.001448434,0.0002102615,0.00001833008,0.0001385824],"genre_scores_gemma":[0.9976113,0.0005909723,0.000597993,0.0002293474,0.0002115898,0.00006365724,0.0004847633,0.00005698014,0.0001533458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1704605,"threshold_uncertainty_score":0.9998345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01257345691671655,"score_gpt":0.3092272931367638,"score_spread":0.2966538362200472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}